Morocco has emerged as a success story in the Middle East and North Africa region and has made significant progress in public health in recent years, including a sharp decline in maternal and infant mortality and new HIV infections. The country was the first Arab country to introduce harm reduction programs for people who inject drugs.

HIV prevalence among the country’s general population is low, and the number of new HIV infections declined by 37 percent between 2010 and 2016. However, it remains high among men who have sex with men, people who inject drugs and female sex workers. While the expansion of screening programs in the past decade has kept the tuberculosis burden largely stable, the low level of treatment adherence is contributing to the emerging problem of multidrug-resistant TB.

Morocco recently completed a transition readiness assessment to prepare for a sustainable response to the diseases once no longer eligible for Global Fund grants.

Investments to Date

Component Signed Committed Disbursed

Disbursements by Component


For documents pertaining to a specific grant, please select a grant from the list.